(PharmaNewsWire.Com, May 11, 2017 ) According to the report published by Market Data Forecast named Asia-Pacific Diagnostic Imaging Market, the market is estimated at $6.98 billion in 2016 and poised to grow $9.74 billion by 2021 with a CAGR of 6.90% in the forecast period.
Diagnostics imaging is technique to create or duplicate representation of human body to diagnose diseases in a patient’s body. It works on principle of sending radio waves or magnetic sound through our body which bounces of a metal surface. These devices aid in creating a databank of normal anatomy and physiology of internal organs so that any irregularity can be observed immediately.
Diagnostics imaging has transformed the way of diagnosis process and has better efficiency of diagnosis to a higher level. With the recent technological advancements diagnostics imaging has been utilized widely over the world for better accuracy in diagnosis. 3D technology is one of the popular imaging techniques that is growing rapidly in Asian market.
The report also presents detailed analysis of various drivers driving the Diagnostics Imaging market as well as constraints of the market that binds it. Some of those factors are • Prevalence of cancer, cardiovascular and chronic diseases • Increasing geriatric population. • Recent technological advancement in diagnosis techniques. • Increasing investments in R&D.
For granular understanding Diagnostics Imaging Market is segmented by type and application. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
The Asia-Pacific Diagnostic Imaging market is segmented based on Type and Application. The market for Diagnostic Imaging, on the basis of type is segmented into X-Rays, Nuclear Medicine, Ultrasound, MRI, Tomography, Photoacoustic Imaging, Thermography, Tactile Imaging, Elastography, and Functional near infrared spectroscopy, Echocardiography. Each modality is further separated into sub segments. The X-ray and ultrasound systems market is segmented on the basis of technology and portability respectively. The nuclear imaging systems market is characterized into Scintigraphy, PET Imaging, and SPECT Imaging. On the basis of Application, the Diagnostic Imaging market is segmented into Cardiology, Oncology, Neurology, Orthopaedics, Gastroenterology, Gynaecology, and Others. Tomography is a widely used method as it increases the chances of cancer discovery and decreases the cases of the patient being called for further tests. 3D imaging is anticipated to grow in all markets during the forecast period.
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. China leads the Diagnostic Imaging market in this region. The Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to reasons such as rising aging population, increasing medical tourism in APAC countries, and favourable administrative policies for the modernization of healthcare infrastructure.
he major companies dominating the market in this region are GE Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Hologic Inc., Fujifilm Corporation, and Shimadzu Corporation
The Asia-Pacific Diagnostics Imaging Market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of type and application along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market.
About us Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
